4//SEC Filing
Mack David Henry 4
Accession 0001415889-25-019380
CIK 0001699382other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 7:48 PM ET
Size
7.9 KB
Accession
0001415889-25-019380
Insider Transaction Report
Form 4
Mack David Henry
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-07-01$1.06/sh−58,411$62,179→ 536,133 total
Holdings
- 147,915(indirect: See footnote)
Common Stock
- 165,307(indirect: See footnote)
Common Stock
- 56,978(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.
- [F2]Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025.
- [F3]The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F4]The shares are held of record by the Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
- [F5]The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
Documents
Issuer
PMV Pharmaceuticals, Inc.
CIK 0001699382
Entity typeother
Related Parties
1- filerCIK 0001341642
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 7:48 PM ET
- Size
- 7.9 KB